Share on StockTwits

Stryker (NYSE:SYK) Director Ronda E. Stryker unloaded 14,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $82.44, for a total transaction of $1,154,160.00. Following the sale, the director now directly owns 174,605 shares in the company, valued at approximately $14,394,436. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Stryker (NYSE:SYK) traded up 0.63% on Friday, hitting $83.19. The stock had a trading volume of 503,551 shares. Stryker has a 52-week low of $66.44 and a 52-week high of $86.93. The stock has a 50-day moving average of $81.42 and a 200-day moving average of $81.6. The company has a market cap of $31.494 billion and a P/E ratio of 46.18.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 17th. The company reported $1.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.08. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company posted $1.00 earnings per share. Stryker’s revenue was up 6.8% compared to the same quarter last year. Analysts expect that Stryker will post $4.77 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 1.48%. The ex-dividend date is Friday, September 26th.

A number of analysts have recently weighed in on SYK shares. Analysts at Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, August 12th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $86.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $90.00 price target on the stock, up previously from $85.00. Eight analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Stryker has an average rating of “Buy” and a consensus price target of $86.18.

Stryker Corporation (NYSE:SYK) is a medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.